Cannula

Global Oxygen Therapy Market Report 2021-2026: Increasing Prevalence of Various Respiratory Disorders, Such as Pneumonia, CF, Asthma, Dysplasia and Sleep Apnea Creates Positive Outlook - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 27, 2022
General Health, Medical Devices, Hospitals, Health, Medical Supplies, Oxygen, Physician, Surgeon, Pneumonia, Asthma, COVID-19, POC, Nicotine, Prevalence, Hypoxia, Research, Degenerative disease, Carbon, Cannula, Blood, Dysplasia, Efficiency, Industry, Cystic fibrosis, Sleep apnea, Smokeless tobacco, Hypoxemia, Patient, CAGR, R, Health care, Beauty salon, Hospital, Pharmaceutical industry, Potash, Growth

The "Oxygen Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Oxygen Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • Looking forward, the global oxygen therapy market to grow at a CAGR of around 10% during the forecast period (2021-2026).
  • Oxygen therapy, or supplemental oxygen, refers to a medical treatment that involves using an additional oxygen source to manage the blood oxygen levels and prevent carbon monoxide toxicity.
  • Additionally, the development of cost-effective, rapid and accurate oxygen therapy devices and the increasing preference for oxygen therapy among doctors, physicians, surgeons and patients are also creating a positive outlook for the market.

Capillary Biomedical Receives FDA Approval to Begin Pivotal Trial of Its SteadiFlow Seven-Day-Wear Infusion Set Technology

Retrieved on: 
Wednesday, January 19, 2022
FDA, Diabetes, Medical Devices, Health, Clinical Trials, Ageing, Patient, Technology, Insulin, Inflammation, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Extended-wear hearing aid, IDE, Pain, Cannula, Skin, Diabetes, Insulin aspart, CRO, Quality of life, Doctor of Philosophy, MD, Food, FDA, Maintenance, Medical device, Insulin lispro

Medical device developer Capillary Biomedical, Inc. (CapBio) has announced that it has received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to start a pivotal trial for the assessment of its SteadiFlow seven-day-wear infusion set technology.

Key Points: 
  • Medical device developer Capillary Biomedical, Inc. (CapBio) has announced that it has received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to start a pivotal trial for the assessment of its SteadiFlow seven-day-wear infusion set technology.
  • CapBios SteadiSet infusion set, powered by its SteadiFlow technology platform, is designed to increase the wear time of insulin infusion sets by addressing the common causes of infusion site failure.
  • With this pivotal trial we are pleased to be taking a significant next step in the evolution of our SteadiFlow infusion set, said CapBio CEO Paul Strasma.
  • The Companys first product, the SteadiSet infusion set featuring SteadiFlow technology, is designed to improve the comfort, reliability and predictability of insulin pump therapy.

Global Wearable Injectors Market Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2015-2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 5, 2022
Pharmaceutical, Health, Medical Devices, Cannula, COVID-19, CAGR, Skin, Research, Syringe, Patient, Prevalence, Cancer, Tissue, Smartphone, Diabetes, Degenerative disease, MI, Pain, Bluetooth, Rheumatoid arthritis, Technology, Industry, Pet, Pharmaceutical industry, Medical device, Potash, Growth

The "Wearable Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Wearable Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • Wearable injectors, or patch pumps, are compact drug delivery devices used for single-step administration of medicines for longer durations.
  • What has been the impact of COVID-19 on the global wearable injectors market?
  • What is the structure of the global wearable injectors market and who are the key players?

PDO Max® Expands its Training Force as Non-Invasive Facial Rejuvenation Procedures Surge in Popularity

Retrieved on: 
Monday, December 20, 2021
Skin, Review, FDA, Physician, CEO, Miss Divine Beauty, PDO, DNP, MAX, Ben-David, MS, Patient, Growth, Cannula, Dentistry

PDO Max trainers have trained under Clinical Director, Dina BenDavid, DNP, MS, FNP-C, and have superior knowledge when it comes to PDO thread placement.

Key Points: 
  • PDO Max trainers have trained under Clinical Director, Dina BenDavid, DNP, MS, FNP-C, and have superior knowledge when it comes to PDO thread placement.
  • Trainers from all over will gather together to review best practices, exchange wisdom on PDO thread procedures, and learn advanced PDO thread placement techniques during live demonstrations.
  • PDO Max offers both group and individual instructional courses, which cover the application of PDO techniques.
  • For more information regarding PDO MAX threads, to place an order, or to attend an educational seminar, please contact PDO MAX at 800-670-0225 or visit https://www.pdomax.com .

Intuitive receives FDA clearance for 8 mm SureForm 30 Curved-Tip Stapler

Retrieved on: 
Wednesday, December 15, 2021
U.S. Securities and Exchange Commission, Solution, FDA, Physician, Industry, Ion, Risk, Cannula, Form 10-K, Dissection, Annual report, Safety, Leadership, Da Vinci Surgical System, Â, Surgeon, Intuitive Surgical, Anatomy, GLOBE, Technology, Dentistry

The 8 mm SureForm 30 stapler is expected to launch in the U.S. in 2022, with other countries to follow.

Key Points: 
  • The 8 mm SureForm 30 stapler is expected to launch in the U.S. in 2022, with other countries to follow.
  • As it fits through the 8 mm da Vinci surgical system instrument cannula, the stapler allows different angles for surgeons to approach patient anatomy.
  • The 8 mm SureForm 30 curved tip stapler achieves this while providing stapling performance surgeons have grown to trust, said Bob DeSantis, Intuitives executive vice president and chief product officer.
  • As with the other SureForm staplers, the 8 mm SureForm 30 Curved-Tip Stapler integrates SmartFire technology software that optimizes staple line performance by measuring tissue compression before and during staple firing.

$673 Million Extracorporeal Membrane Oxygenation Machine (Neonates, Pediatrics and Adults) Markets - Global Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 16, 2021
Medical Supplies, Medical Devices, Health, Hospitals, General Health, Cardiology, Method, ECPR, Google Images, Tuberculosis, Nipro, Portable, Radiation, Component, Diagnosis, Growth, Adult, Degenerative disease, Incidence, Infant, USD, Osteoporosis, Adoption, Cannula, Lung, CAGR, Getinge Group, Pediatrics, Medtronic, MTS Systems Corporation, CVD, Patient, Disease, Light, Paola Lattus, Fracture, Region, Prevalence, Fresenius Medical Care, Investment, Extracorporeal membrane oxygenation, Oxygen, ECMO, Blood, High-dependency unit, Breathe Me, Technology, Heart, LivaNova, Medical device, Pharmaceutical industry

The "Global Extracorporeal Membrane Oxygenation Machine Market by Product, Component, Patient Type (Neonates, Pediatrics and Adults), Modality Outlook (Veno-Venous, Veno-Arterio and Arterio-Venous), Applications, and Region - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Extracorporeal Membrane Oxygenation Machine Market by Product, Component, Patient Type (Neonates, Pediatrics and Adults), Modality Outlook (Veno-Venous, Veno-Arterio and Arterio-Venous), Applications, and Region - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The global ECMO machine market is expected to reach USD 673 million by 2026 from an estimated USD 531 million in 2021, at a CAGR of 4.9% from 2021 to 2026.
  • The goal of the ECMO is to let the heat and lungs recover while the patient is supported by the ECMO machine.
  • The ECMO machine market is dominated by Fresenius Medical care AG & Co. KGaA(Germany), Getinge Group (Sweden), Microport (China).

DKT WomanCare Strengthens Contraceptive Portfolio Through Global Partnership with Key IUD Manufacturer

Retrieved on: 
Tuesday, November 30, 2021
General Health, Other Retail, Supermarket, Oncology, Consumer, Medical Devices, Convenience Store, Other Manufacturing, Retail, Women, Medical Supplies, Health, Manufacturing, Social marketing, Birth, World Health Organization, UNFPA, Partnership, WHO, Woman, World, RH, Cannula, COVID-19, Vaccination, Condom, DKT International, CIC, Research, Intrauterine device, IUS, Organization, DKT, Birth control

WomanCare Global Trading CIC ( DKT WomanCare ) and Pregna International Ltd. ( Pregna ) announce a partnership to increase the availability of intrauterine contraceptives worldwide.

Key Points: 
  • WomanCare Global Trading CIC ( DKT WomanCare ) and Pregna International Ltd. ( Pregna ) announce a partnership to increase the availability of intrauterine contraceptives worldwide.
  • DKT WomanCare is part of DKT International , one of the largest providers of family planning products and services worldwide.
  • This partnership will add IUDs to a global and diverse family planning portfolio that already includes contraceptive implants , injectables , condoms, and various oral tablet formulations.
  • DKT is expanding its portfolio to include Pregna IUDs, injectables, condoms, contraceptive pills, and other innovative pregnancy-prevention methods.

Inspira Technologies Files a PCT Patent Application for its Novel Dual Lumen Cannula Used for Blood Oxygenation

Retrieved on: 
Wednesday, November 10, 2021
ART, Patent Cooperation Treaty, Form, Cannula, WIPO, Unitary state, Proton Inspira, Infection, CEO, PCT, Food, OXY, Regulation of tobacco by the U.S. Food and Drug Administration, Human, Risk, World Intellectual Property Organization, Carbon, Company, Failure rate, Oxygen, SEC, Physician, Patent, Bleeding, Patient, FDA, Medical imaging, Pharmaceutical industry

The main potential advantage of Inspira Technologies' innovative dual lumen cannula lies in the user experience (i.e.

Key Points: 
  • The main potential advantage of Inspira Technologies' innovative dual lumen cannula lies in the user experience (i.e.
  • Dual lumen cannula insertion resembles the technique used for single lumen cannula insertion.
  • Inspira Technologies' dual lumen cannula is designed to reduce complications such as bleeding and infection, improving patient outcomes.
  • Inspira Technologies' dual lumen cannula can be inserted into a large blood vessel without fluoroscopic guidance, at the patient's bedside.

TheraCell Receives 2021 Spine Technology Award For Its Novel TheraFuze DBF® Fiber Anchor™

Retrieved on: 
Wednesday, November 10, 2021
MIS, Cannula, Doctor of Philosophy, Technology, North American Spine Society, CA, Standard of care, Research, Publication, Spine, Invention, Bone, NASS, OTW, Laboratory, Orthopedic surgery, Surgeon, Antibiotics

We are proud to recognize TheraCell's Fiber Anchor as an exemplary and innovative spine surgery product.

Key Points: 
  • We are proud to recognize TheraCell's Fiber Anchor as an exemplary and innovative spine surgery product.
  • "We are honored to be acknowledged by OTW as a Spine Technology Award winner for our Fiber Anchor product", said Andy Carter, PhD, TheraCell's Chief Technology Officer and co-inventor of the TheraFuze DBF Fiber Anchor.
  • The TheraFuze DBF Fiber Anchor is part of TheraCell's comprehensive portfolio of TheraFuze DBF procedure-specific graft solutions, including the TheraFuze DBF Fiber Bag and TheraFuze DBF Fiber Wrap for graft containment, TheraFuze DBF Fiber Bullets for delivery through a cannula in MIS cases, and 1, 2, and 3-level TheraFuze DBF Fiber Boats.
  • TheraFuze DBF, Fiber Anchor, Fiber Bullet, Fiber Bag, Fiber Wrap and Fiber Boat are trademarks of TheraCell, Inc.
    For more information on these products, please visit TheraCell's website .

Global Nasal Cannula Market Analysis 2021-2028 by Type (Low Flow, High Flow), Material (Plastic, Silicone), & End-use (Hospitals, Ambulatory Healthcare Services, Long Term Care Centers) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 6, 2021
Health, Medical Supplies, Medical Devices, CAGR, Adoption, Asia, Air pollution, COPD, COVID-19, Patient, Asthma, Growth, Prevalence, Degenerative disease, USD, Cannula, Hospital, Smoker, Pharmaceutical industry

The "Global Nasal Cannula Market Size, Share & Trends Analysis 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Nasal Cannula Market Size, Share & Trends Analysis 2021-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global nasal cannula market size is expected to reach USD 9.8 billion by 2028.
  • The rise in prevalence of respiratory diseases and the growing geriatric population contribute majorly to the growth of the market.
  • The recent developments in high-flow nasal cannula facilitate expanding the usage at low-level healthcare settings or home use leading to further market growth.